Adamis Pharmaceuticals announces closing of public offering of common stock
Adamis announced the closing of its underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $3.50 per share, as well as 642,857 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted underwriters. April 26, 2017